Health
Breakthroughs and beating the odds.
First Participants Vaccinated in Lassa Fever Vaccine Trial in Ghana
The University of Oxford's vaccine trial against Lassa fever has begun, with participants vaccinated in Ghana.
Study Links Nature Contact to Healthier Eating Habits
Research indicates that increased contact with nature is associated with healthier eating habits and improved dietary choices.
Cambridge completes first human trial of pan-sarbecovirus vaccine
The University of Cambridge has successfully completed a Phase 1 trial of an AI-designed vaccine against sarbecoviruses.
Bepirovirsen shows significant functional cure rates in hepatitis B trials
GSK's bepirovirsen achieved notable functional cure rates in phase 3 trials for chronic hepatitis B, impacting global health.
Gavi Reports Over $30 Billion Economic Benefits from Immunization
Immunizations in lower-income countries generated over $30 billion in economic benefits in 2025, according to Gavi.
FDA Approves First Drug for Alexander Disease Treatment
The FDA approved Zanvastro, the first disease-modifying treatment for Alexander disease, on October 12, 2026.
WRSs2 Shigella vaccine shows 89% efficacy in Phase 2 trial
A Phase 2 trial of the WRSs2 Shigella vaccine candidate showed 89% efficacy, marking a significant advancement in vaccine research.
Moderna and Merck's mRNA Cancer Vaccine Shows Success in Phase 3 Trial
The mRNA cancer vaccine developed by Moderna and Merck met important trial endpoints for melanoma treatment.
India Achieves Over 8 Million HPV Vaccine Doses for Girls
India's HPV vaccination campaign has successfully administered over 8 million doses, targeting cervical cancer prevention in girls.
FDA Approves Ensitrelvir as First Oral COVID-19 Prophylaxis
The FDA has approved ensitrelvir (Xocova) as the first oral treatment for COVID-19 post-exposure prevention in adults and adolescents.
Rotavirus vaccine reduces mortality from gastroenteritis by 76%
A study shows that the rotavirus vaccine significantly reduces deaths from rotavirus-positive acute gastroenteritis in children.
Expanded immunisation programme saves over 51 million lives in Africa
The Expanded Programme on Immunisation has saved 51.2 million lives in Africa over 50 years, according to WHO.
FDA approves first drug for Alexander disease
The FDA has approved Zanvastro as the first disease-modifying treatment for Alexander disease, a rare neurological condition.
Measles Vaccinations Prevent Nearly 20 Million Deaths in Africa
Vaccination efforts have averted nearly 20 million measles-related deaths in Africa since 2000, according to WHO and Gavi.
Gavi vaccines prevent 2.2 million deaths in 2025
Gavi-supported vaccines saved over 2.2 million lives in 2025, reaching a record number of immunizations for children.
Moderna and Merck's mRNA cancer vaccine shows success in Phase 3 trial
A new mRNA cancer vaccine by Moderna and Merck shows significant success in a Phase 3 trial for melanoma.
GSK and Ionis achieve Phase 3 success for hepatitis B treatment
GSK and Ionis Pharmaceuticals report significant progress in hepatitis B treatment with bepirovirsen, showing potential functional cures.
mKRAS-VAX vaccine shows promise in preventing pancreatic cancer
A trial found mKRAS-VAX vaccine induced immune responses in 90% of high-risk participants, with no cancer development after 16.5 months.
Global study shows rotavirus vaccine cuts deaths from gastroenteritis by 76%
A global study finds that the rotavirus vaccine significantly reduces deaths from rotavirus-positive gastroenteritis in children.
FDA Approves First Oral Prophylactic for COVID-19 Prevention
The FDA has approved Shionogi’s Xocova as the first oral medication for post-exposure COVID-19 prophylaxis.
Cambridge Completes First Human Trial of Sarbecovirus Vaccine
Researchers at the University of Cambridge completed the first human trial of an AI-designed vaccine targeting sarbecoviruses.
UCLA trial shows promising results for off-the-shelf cancer vaccine
A new off-the-shelf cancer vaccine targeting KRAS mutations shows strong immune responses in pancreatic and colorectal cancer patients.
Chile eliminates leprosy and rabies as public health problems
Chile has been recognized for eliminating leprosy and dog-transmitted rabies, achieving major public health milestones.
Thailand eliminates rubella as a public health concern
Thailand has successfully eliminated rubella, recognized by WHO as a major milestone in public health.
Pfizer-Valneva Lyme disease vaccine shows 73.2% efficacy in trial
The investigational Lyme disease vaccine PF-07307405 demonstrates 73.2% efficacy in a phase 3 trial.
Optogenetic therapy enhances vision in patients with retinitis pigmentosa
A clinical study shows optogenetic therapy improved light sensitivity in 10 patients with advanced retinitis pigmentosa.
FDA Approves Ensitrelvir as First Oral COVID-19 Prophylaxis
The FDA has approved ensitrelvir, the first oral medication for post-exposure prevention of COVID-19, effective for adults and adolescents.
51.2 Million Lives Saved in Africa Through Expanded Immunisation
Over 51 million lives have been saved in Africa due to vaccines under the Expanded Programme on Immunisation.
GSK's Bepirovirsen Achieves Functional Cure in Hepatitis B Trials
GSK's drug bepirovirsen achieved a functional cure in 19% of participants in Phase 3 trials.
Phase 1 Trial Shows Promising Results for KRAS Vaccine in Cancer
A trial of the ELI-002 2P vaccine showed 84% of patients developed strong immune responses.
Gene Therapy Shows High Success Rate for Children with ADA-SCID
A gene therapy trial successfully restored immune function in 48 of 50 children with ADA-SCID, offering new hope for treatment.
FDA approves first gene therapy for severe leukocyte adhesion deficiency-I
The FDA has approved Kresladi, a groundbreaking gene therapy for severe leukocyte adhesion deficiency-I, developed at UCLA.
Malaria Vaccine RTS,S Averts 1 in 8 Child Deaths in Pilot Countries
The RTS,S malaria vaccine has significantly reduced child mortality, averting 1 in 8 deaths in Ghana, Kenya, and Malawi.
Gavi Vaccination Programs Yield $30 Billion Economic Benefits in 2025
Gavi's vaccination efforts generated over $30 billion in economic benefits in 2025, immunizing 73 million children.
Roswell Park Trial Shows Cancer Vaccine Improves Glioblastoma Survival
Roswell Park Comprehensive Cancer Center reports promising results from a cancer vaccine trial, extending survival for glioblastoma patients.
FDA approves ensitrelvir as first oral antiviral for COVID-19 prevention
The FDA has approved ensitrelvir as the first oral antiviral for post-exposure prophylaxis against COVID-19 in the U.S.
Caitlin Clark shines in WNBA and World Cup 2026
Caitlin Clark achieved career-best statistics in the 2026 WNBA season and contributed to Team USA's World Cup gold.
New Method Targets Gum Disease Without Killing Beneficial Bacteria
A novel approach disrupts harmful bacterial signals to improve oral health without harming beneficial bacteria.
Gene Therapy Shows 95% Success in Treating ADA-SCID in Children
A UCLA-led study found gene therapy restored immune function in 59 of 62 children with ADA-SCID, a rare genetic disorder.
Stanford Researchers Discover Method to Regrow Cartilage in Mice
Stanford scientists found a way to regrow knee cartilage in aged mice by blocking an age-related protein.
Vitamin C Trial Shows Reduced Deaths in Blood Disorder Patients
A phase 2 trial found vitamin C linked to fewer deaths and complications in patients with blood disorders.
Gene Therapy Successfully Restores Hearing in Children
Otarmeni, the first FDA-approved gene therapy for deafness, has restored hearing in many children with OTOF mutations.
Johns Hopkins Vaccine mKRAS-VAX Demonstrates Durable Immune Response in Pancreatic Cancer Trial
The mKRAS-VAX vaccine shows durable T-cell responses in 90% of participants in a pancreatic cancer trial, with no cancer development.
UCLA gene therapy shows 95% success in ADA-SCID treatment
A UCLA-led study reveals 95% success in restoring immune function in children with ADA-SCID through gene therapy.
FDA Approves First Oral Antiviral for COVID-19 Prevention
The FDA has approved ensitrelvir (Xocova) for COVID-19 post-exposure prophylaxis, showing a 67% reduction in symptomatic infections.
500 rural health facilities in Madagascar receive solar power
Madagascar's 500 rural health facilities now have reliable solar power for nighttime care and vaccine refrigeration.
Eight-week hepatitis C treatment shows 98.8% cure rate
A study found an eight-week hepatitis C regimen cures 98.8% of patients, nearly matching the standard 12-week treatment.
India approves Takeda's dengue vaccine Qdenga for ages 4 to 60
India has approved its first dengue vaccine, Qdenga, showing 80.2% efficacy against symptomatic dengue.
India introduces CRISPR therapy BIRSA 101 for sickle cell disease
India has launched BIRSA 101, its first indigenous CRISPR-based gene therapy for sickle cell disease, developed by CSIR-IGIB.
CRISPR Therapy CTX310 Reduces LDL Cholesterol by Over 50 Percent for One Year in Trial
A single infusion of the CRISPR-Cas9 therapy CTX310 achieved significant and sustained reductions in LDL cholesterol and triglycerides during a Phase 1a clinical trial for lipid disorders.